1. Home
  2. Labeler Index
  3. Edenbridge Pharmaceuticals Llc.
  4. 42799-709
  5. NDC Package Code: 42799-709-15 Yargesa

NDC Package 42799-709-15 Yargesa

Miglustat Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
42799-709-15
Package Description:
1 BLISTER PACK in 1 CARTON / 15 CAPSULE in 1 BLISTER PACK
Product Code:
42799-709
Proprietary Name:
Yargesa
Non-Proprietary Name:
Miglustat
Substance Name:
Miglustat
Usage Information:
Miglustat is used for the long-term treatment of a certain rare genetic problem (Gaucher's disease). It works by decreasing the amount of a certain natural fatty substance (glucosylceramide) that builds up due to this condition. This can help improve symptoms of Gaucher's disease, such as tiredness, pain in the joints/bones, and a swollen liver or spleen.
11-Digit NDC Billing Format:
42799070915
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Edenbridge Pharmaceuticals Llc.
Dosage Form:
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
MIGLUSTAT 100 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA209821
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
08-06-2020
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
42799-709-016 BLISTER PACK in 1 CARTON / 15 CAPSULE in 1 BLISTER PACK

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 42799-709-15?

The NDC Packaged Code 42799-709-15 is assigned to a package of 1 blister pack in 1 carton / 15 capsule in 1 blister pack of Yargesa, a human prescription drug labeled by Edenbridge Pharmaceuticals Llc.. The product's dosage form is capsule and is administered via oral form.

Is NDC 42799-709 included in the NDC Directory?

Yes, Yargesa with product code 42799-709 is active and included in the NDC Directory. The product was first marketed by Edenbridge Pharmaceuticals Llc. on August 06, 2020 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 42799-709-15?

The 11-digit format is 42799070915. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-242799-709-155-4-242799-0709-15